fbpx

Publications and Presentations

Explore some of the publications supporting our products and services

Keva Health’s digital platform leverages leading clinical research in the field of pulmonary care to improve patient’s health outcomes.

Person performing a spirometry test for Asthma or COPD while referring to their phone.

Spirometry is a safe, practical, and easy breathing test to perform for Asthma and COPD.

Read more:

Office Spirometry in Primary Care for the Diagnosis and Management of COPD: National Lung Health Education Program Update (2018)

Spirometry Utilization Among Patients with Asthma (2020)

Diagnosis and early detection of COPD using spirometry (2014)

Laptop showcasing a person using spirometer and stethoscope.

Better Asthma control observed in patients with digital intervention.

Read more:

Impact of a digital health intervention on asthma resource utilization
(2018)

Remote FEV1 Monitoring in Asthma Patients: A Pilot Study (2020)

Home self-monitoring in patients with asthma using a mobile spirometry system (2020)

Digital monitoring of COPD

Digital remote monitoring helps reduce COPD readmissions.

Read more:

Exploring the potential benefits of digital health technology for the management of COPD (2019)

Remote Patient Monitoring for the Detection of COPD Exacerbations (2020)

Unique Combination of Remote Monitoring and Exacerbation Prediction to SupportPreventative Management of COPD Exacerbations (2021)

Mobile monitoring and a stethoscope

Home monitoring improves efficiency of therapeutics for Pulmonary Fibrosis

Read more:

Daily Home Spirometry: An effective tool for detecting progression in Idiopathic  Pulmonary Fibrosis (2016)

Remote Monitoring in Idiopathic Pulmonary Fibrosis: Home Is Where the Bluetooth-enabled Spirometer Is (2020)

Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis (2016)

Keva's features displayed on a desktop and a phone

Keva365 respiratory care platform helps in preventing unnecessary ER visits through patient engagement

Read more:

Arrow-up

Reg CF Disclaimer

No money or other consideration is being solicited, and if sent in response, will not be accepted. No offer to buy the securities can be accepted and no part of the purchase price can be received until the offering statement is filed and only through an intermediary’s platform. An indication of interest involves no obligation or commitment of any kind. “reserving” securities is simply an indication of interest.